Vylor has no usable price this run, so there is no trade setup; the fundamentals show strong cash conversion and a low PEG but declining revenue.
Thesis pillars
- Missing Price Data Gap↓Deteriorating
- Strong Cash Conversion→Stable
- Low Peg Valuation↓Deteriorating
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Oct 18, 2026
Vylor Inc. (VYLR) Stock Analysis
Range Bound setup
Financial Services · Shell Companies
Hold if already holding. Not a fresh buy at $72.32, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Weak overall score: 4.9/10.
Vylor Inc. operates as a seed and genetics company. It delivers a pipeline in the industry's elite germplasm and transformative sciences, such as biotechnology and gene editing. The company was founded in 1802 and is based in Johnston, Iowa.
Hold if already holding. Not a fresh buy at $72.32, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Weak overall score: 4.9/10. Chart setup: RSI 49 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Score 4.9/10, moderate confidence.
Passes 6/8 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: moderate.
Recent developments
updated 2026-10-29Recent Developments — Vylor Inc.
Latest news
- NEWS Vylor Announces $3B Buyback Plan — benzinga Oct 22, 2026 positive
- NEWS This Entegris Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday — benzinga Oct 14, 2026 positive
- NEWS BNP Paribas Initiates Coverage On Vylor with Neutral Rating, Announces Price Target of $75 — benzinga Oct 14, 2026
- NEWS UBS Initiates Coverage On Vylor with Buy Rating, Announces Price Target of $89 — benzinga Oct 12, 2026 positive
- NEWS Jim Cramer Gives Green Light To This Health Care Stock — benzinga Oct 12, 2026 neutral
Generated 2026-10-29T11:08:52Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Revenue shrinking — -1.2% YoY. Growth thesis broken unless recovery story develops.static
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $72.32, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Weak overall score: 4.9/10. Chart setup: RSI 49 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Analyst target $71.90 reached (−0.6%), stop $67.26 (−7.5%), A.R:R -0.1:1. Score 4.9/10, moderate confidence.
Analyst target $71.90 reached (−0.6% from $72.32); no take-profit level is published. Analyst target $71.90 reached (−0.6%), stop $67.26 (−7.5%), A.R:R -0.1:1. Stop-loss: $67.26.
Analyst target reached - limited upside remaining; Weak overall score: 4.9/10; Weak growth.
Vylor Inc. trades at a P/E of 103.3 (forward 27.7). TrendMatrix value score: 5.5/10. Verdict: Hold.
What does Vylor Inc. do?Vylor Inc. operates as a seed and genetics company. It delivers a pipeline in the industry's elite germplasm and...
Vylor Inc. operates as a seed and genetics company. It delivers a pipeline in the industry's elite germplasm and transformative sciences, such as biotechnology and gene editing. The company was founded in 1802 and is based in Johnston, Iowa.